Cite
APA Citation
Ottmann, O. G., Müller‐Tidow, C., Krämer, A., Schlenk, R. F., Lübbert, M., Bug, G., Krug, U., Bochtler, T., Voss, F., Taube, T., Liu, D., Garin‐Chesa, P., & Döhner, H. (2019). phase I dose‐escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. British journal of haematology, 184, 1018–1021. http://access.bl.uk/ark:/81055/vdc_100078000570.0x000057